Summary
The product Qomatropin HGH 100 IU, manufactured by PHARMAQO, underwent independent testing to verify its authenticity and potency. The sample, with an unknown batch number, was submitted by Pharmaqo Labs (mrp@vitamins.to) and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of rHGH, with a concentration of 4.23 mg / 12.69 IU per vial. The product’s purity was determined to be 97.253%, with 0.033% dimer and related proteins detected.
The testing process began on 25 January 2024, with the sample received on 31 January 2024, and analysis completed on 1 February 2024. While the results confirm a high purity level, scrutiny of manufacturer-submitted samples is essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: Qomatropin HGH 100 IU
- Active Ingredient: Recombinant Human Growth Hormone (rHGH)
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Lyophilized (Freeze-Dried) Powder
Sample Acquisition and Testing
- Task Number: #38203
- Testing Ordered: 25 January 2024
- Sample Received: 31 January 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Specification: 100 IU (as stated on the label)
- Measured Concentration: 4.23 mg / 12.69 IU
- Purity: 97.253%
- Dimer and Related Proteins: 0.033%
Verification Details
- Verification URL: https://janoshik.com/tests/38203_D217XBJENFKK
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the high purity of the tested product but also raises concerns regarding potential bias, as the test was submitted and funded by Pharmaqo Labs. Manufacturers often choose specific batches for testing, which may not fully represent the consistency of products available in the broader market. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, independent validation through third-party testing across multiple batches would further ensure reliability.
Conclusion
The analysis confirms that Qomatropin HGH 100 IU meets a 97.253% purity level, with 12.69 IU detected per vial. While this reflects a strong purity standard, independent testing of multiple batches is encouraged to confirm consistency across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding recombinant human growth hormone (rHGH) products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
